Nephrotic and nephritic syndrome may sound like two similar conditions at first, but they’re actually quite different. Nephrotic syndrome is an umbrella term used to describe a range of kidney diseases that affect the kidneys’ ability to filter proteins from the blood. Nephritic syndrome is an inflammatory disorder that affects the glomeruli, small filters in the kidneys that help filter waste out of the blood. For medical professionals, it's important to understand the distinctions between these two syndromes in order to accurately diagnose and treat patients. In this blog post, we will discuss what nephrotic and nephritic syndrome are, their causes, symptoms, treatment options, and prognosis. We will also explore how diagnosing one over the other can affect patient care and outcomes.
Nephrotic syndrome is a kidney disorder that causes the body to excrete too much protein in the urine. It can also cause edema, or fluid retention, and high cholesterol levels. The most common cause of nephrotic syndrome is damage to the filters in the kidneys, called glomeruli. This damage can be caused by certain diseases, such as diabetes or lupus, or by certain medications. Treatment for nephrotic syndrome focuses on reducing protein loss and treating the underlying cause.
Nephritic syndrome is a kidney disorder that typically results from inflammation of the glomeruli, which are the tiny filters in your kidneys that remove waste and excess water from your blood. The inflammation can be caused by infection, immune system disorders, or other conditions. Nephritic syndrome can lead to kidney damage and failure.
Nephrotic syndrome (NS) and nephritic syndrome (NNS) are separate kidney disorders that have different signs and symptoms. NS is characterized by the loss of large amounts of protein in the urine, which can lead to fluid retention and edema. NNS, on the other hand, is marked by the presence of red blood cells in the urine and is often associated with hypertension. While both conditions can cause renal failure, they require different treatment approaches.
Nephrotic syndrome is a kidney disorder that causes the body to excrete too much protein in the urine. Protein is important for many bodily functions, including fighting infection and keeping the blood from clotting. When there is too much protein in the urine, it can lead to serious health problems, such as malnutrition, infections, and blood clots.
There are many different causes of nephrotic syndrome, including genetic disorders, autoimmune diseases, and certain medications. In some cases, the cause is unknown. Treatment for nephrotic syndrome focuses on managing the symptoms and preventing complications.
Nephrotic syndrome is a kidney disorder that causes the body to excrete too much protein in the urine. Protein is important for many bodily functions, so when it is lost in the urine, a person can become very ill. The most common symptom of nephrotic syndrome is proteinuria, or excessive protein in the urine. Other symptoms can include:
-Edema (swelling), especially in the face, legs, and abdomen
-Weight gain from fluid retention
-Foamy urine
-High cholesterol levels
- Fatigue
-Increased urination at night
There is no one-size-fits-all answer to the question of how best to treat nephrotic syndrome. In general, however, treatment for nephrotic syndrome typically includes medication to suppress the immune system and help reduce inflammation. In severe cases, where kidney function is threatened, plasma exchange or immunosuppressive therapy may be necessary.
In conclusion, knowing the difference between nephrotic and nephritic syndrome is essential for medical professionals. Being able to accurately diagnose each syndrome will help in providing the appropriate treatment for each patient. Nephrotic Syndrome more commonly affects children while Nephritic Syndrome can affect both adults and children alike.
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation